United Capital Financial Advisors LLC lowered its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 22.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,405 shares of the semiconductor company's stock after selling 1,300 shares during the quarter. United Capital Financial Advisors LLC's holdings in Synopsys were worth $2,138,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of SNPS. Pine Valley Investments Ltd Liability Co raised its holdings in Synopsys by 44.8% during the third quarter. Pine Valley Investments Ltd Liability Co now owns 727 shares of the semiconductor company's stock worth $368,000 after purchasing an additional 225 shares in the last quarter. World Investment Advisors LLC purchased a new stake in Synopsys in the third quarter valued at $253,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Synopsys in the 3rd quarter valued at about $865,000. Blankinship & Foster LLC purchased a new position in Synopsys during the 3rd quarter worth approximately $2,772,000. Finally, Synovus Financial Corp increased its position in Synopsys by 199.2% during the third quarter. Synovus Financial Corp now owns 15,062 shares of the semiconductor company's stock worth $7,627,000 after buying an additional 10,028 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
SNPS has been the topic of a number of research reports. Mizuho lowered their target price on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Piper Sandler reduced their target price on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Bank of America decreased their target price on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating for the company in a research note on Wednesday, April 16th. Morgan Stanley dropped their price target on Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research report on Monday, February 24th. Finally, Wells Fargo & Company decreased their price objective on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a research report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $618.31.
Read Our Latest Stock Analysis on SNPS
Insider Buying and Selling at Synopsys
In other news, insider Geus Aart De sold 15,705 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. This trade represents a 11.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the sale, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This represents a 13.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.
Synopsys Stock Up 3.1 %
Shares of SNPS traded up $12.86 during mid-day trading on Wednesday, reaching $426.26. 344,822 shares of the stock traded hands, compared to its average volume of 1,087,452. The stock has a fifty day simple moving average of $441.91 and a 200 day simple moving average of $493.85. The firm has a market cap of $65.91 billion, a price-to-earnings ratio of 29.36, a P/E/G ratio of 3.23 and a beta of 1.23. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $624.80.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.